10.4 Agent & Broker Compensation Rules

Why This Topic Matters

CMS regulates agent and broker compensation as tightly as it regulates marketing conduct, for a simple reason: if a plan can pay an agent more to sell Plan X than Plan Y, the agent has a financial incentive to steer beneficiaries toward the higher-paying plan regardless of fit. This section covers Fair Market Value (FMV), the current dollar caps, and the specific practices CMS prohibits to prevent compensation from distorting what beneficiaries are sold. AHIP tests both the concrete dollar figures and the underlying "why" — recognizing a prohibited compensation structure in a scenario.

Fair Market Value (FMV)

Fair Market Value (FMV) is the maximum amount CMS determines a plan may pay an agent or broker for an enrollment or a continued (renewal) enrollment. No plan, field marketing organization (FMO), or agency may pay an agent more than the FMV cap for an MA or Part D enrollment — doing so risks violating federal anti-kickback law, because above-FMV payments function as an inducement rather than fair compensation for legitimate sales work.

2026 National Compensation Rates

Notice the pattern: for both MA and PDP, the renewal rate is exactly half the initial rate. This is not a coincidence — CMS structures renewal FMV as roughly 50% of the initial-year rate, reflecting that ongoing servicing of an existing enrollee requires less work than the original sale and application. Puerto Rico and the U.S. Virgin Islands use separate (lower) regional rates, since CMS calculates FMV regionally where plan economics differ meaningfully from the mainland.

The "Same Rate" Rule

CMS requires plans to pay the same compensation rate to all of their independent agents and brokers, regardless of which specific plan within their portfolio is sold. This eliminates the incentive to create internal rate variation that pushes agents toward a particular plan — an agent selling Plan A for a carrier must be paid the same rate as one selling that carrier's Plan B, assuming both are the same product type (both MA, or both PDP) and the same enrollment stage (both initial, or both renewal).

Prohibited Compensation Structures

CMS has specifically flagged and prohibited compensation arrangements that create anti-competitive or steering incentives, including:

• Volume-based bonuses — any bonus or incentive tied to hitting a sales volume target for a specific plan, because it creates pressure to push that plan regardless of beneficiary fit
• Non-compete penalty payments — a bonus or contract term that pays (or penalizes) an agent for declining to represent a competing plan
• Above-FMV payments — any total compensation, in any form, that exceeds the CMS-set FMV cap for that product and enrollment stage
• Undisclosed compensation arrangements — plans must report compensation structures and disclose referral fees; hidden arrangements are themselves a violation independent of the dollar amount

Referral Fees

Separate from the FMV commission structure, CMS caps referral fees — payments made to a person (who may not be a licensed agent) for referring a prospective beneficiary to an agent, broker, or other entity for potential enrollment:

Referral fees above these caps risk crossing from a "nominal" thank-you into an inducement that steers the referral source toward one plan — and any referral fee paid must be disclosed.

Reporting and Disclosure to CMS

Compensation compliance is not just a cap on the dollar amount — it also comes with a reporting obligation. Plans must report their compensation structure to CMS through the Health Plan Management System (HPMS), including whether they use employed (captive), independent, or a mix of agents and brokers, and the specific rates or rate ranges paid. This reporting requirement exists precisely so CMS can audit for the patterns described above — a plan that reports one rate publicly but pays a different rate through a side arrangement is exposed the moment CMS cross-checks compensation records against HPMS filings.

It's also worth noting that CMS has, in recent years, moved to fold what plans previously treated as separate "administrative payments" — fees paid to agents or field marketing organizations for non-sales-specific services like data entry or CRM support — directly into the single FMV compensation cap, rather than allowing them as an add-on paid on top of the commission. The intent is the same throughout this section: prevent any channel, whether labeled "commission," "bonus," or "administrative fee," from being used to push total agent compensation above the CMS-set ceiling.

Exam Scenario

An FMO offers agents a $150 bonus for every 10th Medicare Advantage enrollment completed within a calendar quarter, on top of the standard commission. Is this compensation structure compliant?

No. This is a volume-based bonus tied to a sales target for a specific plan type, which CMS explicitly prohibits because it creates an incentive to prioritize hitting the quota over matching beneficiaries to the right plan — regardless of whether the total dollar amount, spread across enrollments, would otherwise stay under the FMV cap.

Takeaways

• Fair Market Value (FMV) is the CMS-set maximum an agent/broker may be paid per enrollment; paying above FMV risks an anti-kickback violation.
• 2026 national rates: MA/MA-PD is $694 initial / $347 renewal; standalone Part D is $114 initial / $57 renewal — renewal is roughly half the initial rate for both.
• CMS requires the same compensation rate across all plans an agent sells for a given carrier and product type, eliminating incentive-driven rate variation.
• Volume-based bonuses, non-compete penalty payments, and above-FMV compensation are all specifically prohibited.
• Referral fees are capped separately at $100 for MA/MA-PD and $25 for PDP, and must be disclosed.
• Plans must report compensation structures to CMS through HPMS, and CMS has moved to fold "administrative payments" into the single FMV cap rather than allowing them as a separate add-on.